Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick Mismetti

Showing results (31-40 of 179) with videos related to

Pageof 18
Sort By:
Journal of Separation Science|June 10, 2010
Ultra-performance LC MS/MS method for quantification of clopidogrel active metaboliteXavier Delavenne, Thierry Basset, Paul Zufferey, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 23, 2022
The impact of advanced age on anticoagulant therapy for acute venous thromboembolismLudovic Lafaie, Thomas Célarier, Manuel Monreal, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 24, 2013
PK evaluation of fondaparinux sodium for the treatment of thrombosisXavier Delavenne, Paul Frappé, Paul Zufferey, et al.
Journal of Vascular Surgery|November 7, 2003
Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosisSara Quenet, Silvy Laporte, Hervé Décousus, et al.
Brain Research|May 24, 2019
Direct oral anticoagulants are associated with limited damage of endothelial cells of the blood-brain barrier mediated by the thrombin/PAR-1 pathwayClémentine Puech, Xavier Delavenne, Zhiguo He, et al.
Frontiers in Immunology|September 30, 2021
The Non-Haemostatic Response of Platelets to Stress: An Actor of the Inflammatory Environment on Regenerative Medicine?Fabrice Cognasse, Hind Hamzeh-Cognasse, Patrick Mismetti, et al.
Presse Medicale (Paris, France : 1983)|July 24, 2013
[New oral anticoagulants in the treatment of venous thromboembolism]Laurent Bertoletti, Jean-Christophe Lega, Nathalie Moulin, et al.
Haematologica|December 23, 2003
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment toolMeyer Michel Samama, Ola E Dahl, Daniel J Quinlan, et al.
Presse Medicale (Paris, France : 1983)|August 5, 2018
Screening cancer after venous thromboembolism: How many abnormal tests before diagnosing cancer? An analysis of practiceCécile Duvillard, Elodie De Magalhaes, Nathalie Moulin, et al.
Vascular and Endovascular Surgery|August 15, 2022
Pathological Analysis and Clinical Evolution After Radiological Removal of Retrievable Vena Cava FiltersThierry Annweiler, Laurent Bertoletti, Sylvain Grange, et al.
Pageof 18

Showing results (31-40 of 179) with videos related to

Sort By:
Pageof 18
Journal of Separation Science|June 10, 2010
Ultra-performance LC MS/MS method for quantification of clopidogrel active metaboliteXavier Delavenne, Thierry Basset, Paul Zufferey, et al.
Expert Opinion on Drug Metabolism & Toxicology|February 23, 2022
The impact of advanced age on anticoagulant therapy for acute venous thromboembolismLudovic Lafaie, Thomas Célarier, Manuel Monreal, et al.
Expert Opinion on Drug Metabolism & Toxicology|December 24, 2013
PK evaluation of fondaparinux sodium for the treatment of thrombosisXavier Delavenne, Paul Frappé, Paul Zufferey, et al.
Journal of Vascular Surgery|November 7, 2003
Factors predictive of venous thrombotic complications in patients with isolated superficial vein thrombosisSara Quenet, Silvy Laporte, Hervé Décousus, et al.
Brain Research|May 24, 2019
Direct oral anticoagulants are associated with limited damage of endothelial cells of the blood-brain barrier mediated by the thrombin/PAR-1 pathwayClémentine Puech, Xavier Delavenne, Zhiguo He, et al.
Frontiers in Immunology|September 30, 2021
The Non-Haemostatic Response of Platelets to Stress: An Actor of the Inflammatory Environment on Regenerative Medicine?Fabrice Cognasse, Hind Hamzeh-Cognasse, Patrick Mismetti, et al.
Presse Medicale (Paris, France : 1983)|July 24, 2013
[New oral anticoagulants in the treatment of venous thromboembolism]Laurent Bertoletti, Jean-Christophe Lega, Nathalie Moulin, et al.
Haematologica|December 23, 2003
Quantification of risk factors for venous thromboembolism: a preliminary study for the development of a risk assessment toolMeyer Michel Samama, Ola E Dahl, Daniel J Quinlan, et al.
Presse Medicale (Paris, France : 1983)|August 5, 2018
Screening cancer after venous thromboembolism: How many abnormal tests before diagnosing cancer? An analysis of practiceCécile Duvillard, Elodie De Magalhaes, Nathalie Moulin, et al.
Vascular and Endovascular Surgery|August 15, 2022
Pathological Analysis and Clinical Evolution After Radiological Removal of Retrievable Vena Cava FiltersThierry Annweiler, Laurent Bertoletti, Sylvain Grange, et al.
Pageof 18